Analysis of amino insertion mutations in the fingers subdomain of HIV-1 reverse transcriptase

Journal of Molecular Biology

Volumn 286, Issue 4, 1999, Pages 995-1008

  Boyer, Paul L ^a   Lisziewicz, Julianna ^b,c   Lori, Franco ^b,c   Hughes, Stephen H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Drug resistance; HIV 1; Reverse transcriptase

Indexed keywords

DIDANOSINE; HYDROXYUREA; RNA DIRECTED DNA POLYMERASE;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; ENZYME ACTIVITY; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS ISOLATION;

EID: 0033525695     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2508     Document Type: Article

References (26)

1. Adachi A., Gendelman H. E., Koenig S., Folks T., Wiley R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:1986;284-291.
2. Ahluwalia G., Cooney D. A., Mitsuya H., Fridland A., Flora K. P., Hao Z., Dalal M., Broder S., Johns D. G. Initial studies on the cellular pharmacology of 2′, 3′-dideoxyinosine, an inhibitor of HIV infectivity. Biochem. Pharmacol. 36:1987;3797-3800.
3. Boyer P. L., Hughes S. H. Analysis of mutations at position 184 in the reverse transcriptase of human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 39:1995;1624-1628.
4. Boyer P. L., Ferris A. L., Hughes S. H. Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J. Virol. 66:1992a;1031-1039.
5. Boyer P. L., Ferris A. L., Hughes S. H. Mutational analysis of the fingers domain of human immunodeficiency virus type I reverse transcriptase. J. Virol. 66:1992b;7533-7537.
6. Boyer P. L., Tantillo C., Jacobo-Molina A., Nanni R. G., Ding J., Arnold E., Hughes S. H. Sensitivity of wild-type human immunodeficiency virus type I reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not. Proc. Natl Acad. Sci. USA. 91:1994;4882-4886.
7. Boyer P. L., Gao H.-Q., Hughes S. H. A mutation at position 190 of human immunodeficiency virus type 1 reverse transcriptase interacts with mutations at position 74 and 75 via the template-primer. Antimicrob. Agents Chemother. 42:1998;447-452.
8. Das A. T., Klaver B., Klasens B. I. F., van Wamel J. L. B., Berkhout B. A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J. Virol. 71:1997;2346-2356.
9. De Antoni A., Foli A., Lisziewicz J., Lori F. Mutations in the pol gene of human immunodeficiency virus type 1 in infected patients receiving didanosine and hydroxyurea combination therapy. J. Infect. Dis. 176:1997;899-903.
10. De Clercq E. HIV resistance to reverse transcriptase inhibitors. Biochem. Pharmacol. 47:1994;155-169.
11. Federoff 0. Y., Ge Y., Reid B. R. Solution structure of r(gaggacug):d(CAGTCCTC) hybrid: implications for the initiation of HIV-1 (+)-strand synthesis. J. Mol. Biol. 269:1997;225-239.
12. Gao W.-Y., Cara A., Gallo R. C., Lori F. Low level of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. Proc. Natl Acad. Sci. USA. 90:1993;8925-8928.
13. Hanke M., Wink M. Direct DNA sequencing of PCR-amplified vector inserts following enzymatic degradation of primer and dNTPs. Biotechniques. 17:1994;858-860.
14. Huang H., Chopra R., Verdine G. L., Harrison S. C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science. 282:1998;1669-1675.
15. Lori F., Malykh A., Cara A., Sun D., Weinstein J. N., Lisziewicz J., Gallo R. C. Hydroxyurea as an inhibitor of human immunodeficiency virus type 1 replication. Science. 266:1994;801-805.
16. Lori F., Malykh A. G., Foli A., Maserati R., De Antoni A., Minoli L., Padrini D., Degli Antoni A., Barchi E., Jessen H., Wainberg M. A., Gallo R. C., Lisziewicz J. Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance. AIDS Res. Human Retroviruses. 13:1997;1403-1409.
17. Mellors J. W., Larder B. A., Schinazi R. F. Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance. Int. Antivir. News. 3:1995;8-13.
18. Myers G., Korber B., Berzofsky J., Smith R. Human Retroviruses and AIDS. 1993;Los Alamos National Laboratory.
19. Richman D. D. Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents. Antimicrob. Agents Chemother. 37:1993;1207-1213.
20. Robson A. B., Graves B. J. Synthesis and processing of viral RNA. Coffin J. M., Hughes S. H., Varmus H. E. Retroviruses. 1997;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
21. Saag M. S., Emini E. A., Laskin O. L., Douglas J., Lapidus W. I., Schleif W. A., Whitley R. J., Hildebrand C., Byrnes V. W., Kappes J. C., Anderson K., Massari F., Shaw G. A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working group. New England J. Med. 329:1993;1065-1072.
22. Tantillo C., Ding J., Jacobo-Molina A., Nanni R. G., Boyer P. L., Hughes S. H., Pauwels R., Andries K., Janssen P. A. J., Arnold E. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase: implications for mechanisms of drug inhibition and resistance. J. Mol. Biol. 243:1994;369-387.
23. Telesnitsky A., Goff S. P. Synthesis and processing of viral RNA. Coffin J. M., Hughes S. H., Varmus H. E. Retroviruses. 1997;205-261 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
24. Werle E., Schneider C., Renner M., Volker M., Fiehn W. Convenient single-step, one tube purification of PCR products for direct sequencing. Nucl. Acids Res. 22:1994;4354-4355.
25. Winters M. A., Coolley K. L., Girard Y. A., Levee D. J., Harridan H., Shafer R. W., Katzenstein D. A., Merigan T. C. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type I confers resistance to multiple nucleoside inhibitors. J. Clin. Invest. 102:1998;1769-1775.
26. Xiping W., Ghosh S., Taylor M., Johnson V., Emini E., Deutsch P., Lifson J., Bonhoeffer S., Nowak M., Hahn B., Saag M., Shaw G. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:1995;117-122.